Platelet endothelial cell adhesion molecule 1 (Pecam1) is an angiogenesis marker that has been suggested to assess the influence of microvessels and angiogenesis on the clinical outcome of breast cancer patients (Martin et al. 2005). Here, PECAM1 is linked to breast carcinoma.